PCYC

Pharmacyclics, Inc. News Headlines

$131.45
*  
1.89
1.42%
Get PCYC Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PCYC After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
12/18/2014 1:00:00 PM - Investopedia


3 Reasons Johnson & Johnson Could Soar in 2015
12/10/2014 8:03:02 AM - Motley Fool


New Use For AMGN's Old Drug, BLUE In The Pink, Cellceutix Gets A Boost
12/9/2014 12:49:00 AM - RTT News


Pharmacyclics (PCYC) Launches U.S.-Based CLL Registry - Analyst Blog
12/8/2014 6:50:00 PM - Zacks.com


Can Pharmacyclics (PCYC) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
12/3/2014 8:41:00 AM - Zacks.com


Pharmacyclics, J&J Seek Imbruvica Label Expansion in EU - Analyst Blog
12/2/2014 6:05:00 PM - Zacks.com


Up 31% in 2014, is Pharmacyclics Stock Still a Buy?
12/1/2014 9:15:02 AM - Motley Fool


Pharmacyclics Says EMA Accepts Type II Variation Application For IMBRUVICA
12/1/2014 3:37:00 AM - RTT News


Get Your Wallet Out: Global Drug Spending is About to Hit a Dubious Milestone
11/23/2014 10:18:03 AM - Motley Fool


Biotech: And Yet We've Just Begun...
11/14/2014 10:06:21 AM - Martin Tillier


Stocks Fluctuating As Traders Digest Mixed Jobs Data - U.S. Commentary
11/7/2014 12:10:00 PM - RTT News


Interest Rate Concerns Contribute To Weakness On Wall Street - U.S. Commentary
11/7/2014 10:05:00 AM - RTT News


Biotech Watchlist Update: Small-Cap Biotechs Struggle, But Investors Remain Enchanted By Big Pharma's Returns
11/7/2014 9:16:00 AM - Seeking Alpha


Pharmacyclics Tops Q3 Earnings, Ties Up with AstraZeneca - Analyst Blog
11/5/2014 12:00:00 PM - Zacks.com


Pharmacyclics Results Top Estimate
11/4/2014 7:15:00 PM - RTT News


Earnings Reaction History: Pharmacyclics Inc., 62.5% Follow-Through Indicator, 4.8% Sensitive
11/4/2014 2:59:24 PM - MT Newswires


After-Hours Earnings Report for November 4, 2014 : FOXA, PXD, FOX, DVN, ATVI, SBAC, PBA, OKE, TRIP, JAZZ, PCYC, XEC
11/4/2014 2:00:03 PM - NASDAQ.com News


The Time Is Now For Northwest Biotherapeutics
10/29/2014 3:16:00 PM - Seeking Alpha


Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog
10/22/2014 12:54:00 PM - Zacks.com


NBIX For The Long Haul, RegeneRx Catches Investors' Eyes, NewLink Inks New Deal
10/20/2014 11:47:00 PM - RTT News


Sector Update: Health Stocks Higher Pre-Bell
10/20/2014 7:54:23 AM - MT Newswires


Sector Update: Health Care
10/20/2014 7:53:17 AM - MT Newswires


Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog
10/17/2014 5:15:00 PM - Zacks.com


IMBRUVICA Gets Marketing Approval From EC For Treatment Of Two Blood Cancers
10/17/2014 9:14:00 AM - RTT News


Sector Update: Health Stocks Higher Pre-Bell
10/17/2014 8:21:20 AM - MT Newswires